Faculty

Institution

Unit

Venue

Na Qiao

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

NoneNa Qiao is currently serving as a Hematopoietic Biology And Malignancy faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Na Qiao

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

immunology cancer immunotherapy immunotherapy cell biology immune responses cellular therapy breast cancer cancer cells oncology leukemia medicinal research immunomodulation tumor biology cancer research breast oncology oncogenes cancer biology experimental medicine cell death antigen processing cancer treatment cancer immunosurveillance peptides cancer care hematological malignancies immune checkpoint inhibitors molecular cancer clinical immunology therapeutic vaccines cellular immune responses medicine hematology peptide science cell research peptide therapeutics vaccine development tumor targeting cancer genetics breast cancer cells dermatology molecular immunology cancer prevention adult t-cell leukemia-lymphoma innate immune system hla typing cell therapy pr1-targeted immunotherapy cellular biochemistry medical mycology clinical transplantation cancer letter cell-matrix interactions cancer risk pancreatic cancer histocompatibility vaccine design clinical mycology cancer management protein expression cell regulation antibody engineering granulocyte subgroup analysis broad cross-presentation solid tumors leads cathepsin g is acute lymphoblastic leukemia potential immunotherapeutic target tumor cells basal-like breast cancers immunotherapeutic targets cyclin e phase ib trial peptide vaccines folate binding protein leader sequence

Notable Scholarly Works

Notable Federal Grants

Collaborators

Immunotherapy Targeting a Leader Sequence Cathepsin G-Derived Peptide. Leukemia (2025)

peptide therapeuticsleader sequencepeptidescellular therapyimmunotherapyimmunologymedicinal researchimmune responsespeptide science

T Cell Receptor Mimic Car T Cells Targeting Cathepsin G Signal Peptide. Leukemia (2025)

receptorscellular immune responsesimmune responsessignal transductioncellular therapycell signalingimmunologycell researchcell biologymolecular immunology

Aml Immunotherapy Using a Novel Tcrm-Based Bispecific Antibody That Targets a Leader Sequence Peptide Derived From Cathepsin G. Blood (2023)

cancer immunotherapycathepsin gimmune responsespeptide therapeuticsaml immunotherapypeptidescellular therapyimmunologyimmunotherapyantibody engineeringcell biologytherapeutic targets

Data From Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response. (2023)

breast cancerimmune responsesinflammationcancer cellstumor microenvironmentbreast oncologycellular therapyimmunologycancer immunosurveillancecell biology

Data From Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes. (2023)

allergycancer immunotherapyadaptive immune systemcellular immune responsesimmunomodulationcell transplantationcellular therapyimmunologyimmunotherapycell therapyimmune responsesantigen processingexperimental medicinefucosylation enhances

Data From Pd-L1 Expression in Triple-Negative Breast Cancer. (2023)

Elizabeth A. MittendorfAnne V. PhilipsFunda Meric-BernstamNa QiaoYun WuSusan HarringtonXiaoping SuYing WangAna M. Gonzalez-AnguloArgun AkcakanatAkhil ChawlaMichael CurranPatrick HwuPadmanee SharmaJennifer K. LittonJeffrey J. MolldremGheath Alatrash

pharmacologycancer immunotherapytriple-negative breast cancerbreast cancerhealth sciencesgene expressioncancer researchoncologycancer genomicsimmunologymedicinal researchcancer care

Data From Trastuzumab Increases Her2 Uptake and Cross-Presentation by Dendritic Cells. (2023)

Victor A. GallAnne V. PhilipsNa QiaoKaren Clise-DwyerAlexander A. PerakisMao ZhangGuy T. CliftonPariya SukhumalchandraQing MaSangeetha M. ReddyDihua YuJeffrey J. MolldremGeorge E. PeoplesGheath AlatrashElizabeth A. Mittendorf

cancer immunotherapyimmunity (medicine)adaptive immune systemcancer cellsspecific resistanceinfectious diseasesinflammationreproductive immunologyimmunomodulationcancer discoverytrastuzumab increasessystems biologyimmunologyimmunotherapycancer immunosurveillanceimmune responsesimmune checkpoint inhibitorsdendritic cells

Supplemental Figure From Trastuzumab Increases Her2 Uptake and Cross-Presentation by Dendritic Cells. (2023)

immunity (medicine)immunomodulationreproductive immunologysupplemental figurecancer cellsimmune responsesmolecular cancerintermediate hostdendritic cellsallergyinflammationcellular therapyimmunologyimmunotherapycancer immunosurveillanceimmune checkpoint inhibitorscancer immunotherapyadaptive immune systemradiation oncologytrastuzumab increasesmedicinal research

Supplemental Figure S7 From Targeting the Leukemia Antigen Pr1 With Immunotherapy for the Treatment of Multiple Myeloma. (2023)

Gheath AlatrashAlexander A. PerakisCeline KerrosHaley L. PetersPariya SukhumalchandraMao ZhangHaroon JakherMadhushree ZopeRebecca PateniaAnna SergeevaShuhua YiKen H. YoungAnne V. PhilipsAmanda M. CernosekHaven R. GarberNa QiaoJinsheng WengLisa S. St JohnSijie LuKaren Clise-DwyerElizabeth A. MittendorfQing MaJeffrey J. Molldrem

cancer immunotherapytumor targetingcancer treatmentoncologyleukemiaimmunotherapyimmunologymultiple myeloma

Supplementary Figure 3 From Pd-L1 Expression in Triple-Negative Breast Cancer. (2023)

cancer biologytriple-negative breast cancerbreast cancercancer researchoncologyradiation oncology

1
2
3
4
10 / page

Na Qiao

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

NoneNa Qiao is currently serving as a Hematopoietic Biology And Malignancy faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Na Qiao

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Immunotherapy Targeting a Leader Sequence Cathepsin G-Derived Peptide. Leukemia (2025)

peptide therapeuticsleader sequencepeptidescellular therapyimmunotherapyimmunologymedicinal researchimmune responsespeptide science

T Cell Receptor Mimic Car T Cells Targeting Cathepsin G Signal Peptide. Leukemia (2025)

receptorscellular immune responsesimmune responsessignal transductioncellular therapycell signalingimmunologycell researchcell biologymolecular immunology

Aml Immunotherapy Using a Novel Tcrm-Based Bispecific Antibody That Targets a Leader Sequence Peptide Derived From Cathepsin G. Blood (2023)

cancer immunotherapycathepsin gimmune responsespeptide therapeuticsaml immunotherapypeptidescellular therapyimmunologyimmunotherapyantibody engineeringcell biologytherapeutic targets

Data From Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response. (2023)

breast cancerimmune responsesinflammationcancer cellstumor microenvironmentbreast oncologycellular therapyimmunologycancer immunosurveillancecell biology

Data From Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes. (2023)

Data From Pd-L1 Expression in Triple-Negative Breast Cancer. (2023)

pharmacologycancer immunotherapytriple-negative breast cancerbreast cancerhealth sciencesgene expressioncancer researchoncologycancer genomicsimmunologymedicinal researchcancer care

Data From Trastuzumab Increases Her2 Uptake and Cross-Presentation by Dendritic Cells. (2023)

Supplemental Figure From Trastuzumab Increases Her2 Uptake and Cross-Presentation by Dendritic Cells. (2023)

Supplemental Figure S7 From Targeting the Leukemia Antigen Pr1 With Immunotherapy for the Treatment of Multiple Myeloma. (2023)

cancer immunotherapytumor targetingcancer treatmentoncologyleukemiaimmunotherapyimmunologymultiple myeloma

Supplementary Figure 3 From Pd-L1 Expression in Triple-Negative Breast Cancer. (2023)

cancer biologytriple-negative breast cancerbreast cancercancer researchoncologyradiation oncology

1
2
3
4
10 / page